Real-time enrollment status for this malignant glioma clinical trial
Current Status
Recruiting
Checked: October 17, 2026 at 10:11 AM UTC
| NCT Number | NCT05030298 |
| Recruiting Status | Recruiting |
| Condition | Malignant Glioma |
| Phase | PHASE1 |
| Target Enrollment | 28 participants |
| Active Locations | 2 sites in the US |
| Sponsor | Mayo Clinic |
| Last Updated on CT.gov | September 30, 2026 (2 weeks ago) |
As of October 17, 2026: Clinical trial NCT05030298 is currently recruiting participants. This phase1 study for malignant glioma is actively seeking new participants at 2 locations across the United States. The study is sponsored by Mayo Clinic. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05030298 is actively recruiting participants as of October 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 2 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05030298 was last updated 2 weeks ago (September 30, 2026). HelloStudys verifies this status automatically.